A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

Autor: Humphrey, R. W., Wyvill, K. M., Nguyen, B.-Y., Shay, L. E., Kohler, D. R., Steinberg, S. M., Ueno, T., Fukasawa, T., Shintani, M., Hayashi, H.
Zdroj: Antiviral Research; 1999, Vol. 41 Issue: 1 p21-34, 14p
Databáze: Supplemental Index
Externí odkaz: